Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Dual threat: Susceptibility mechanisms and treatment strategies for COVID-19 and bacterial co-infections. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
T cells: warriors of SARS-CoV-2 infection [J]
10.1016/j.it.2020.11.002 · 2021 · External reference
Respiratory tract barrier dysfunction in viral-bacterial co-infection cases [J]
10.1016/j.jdsr.2023.12.006 · 2024 · External reference
COVID-19: characteristics and therapeutics [J]
10.3390/cells10020206 · 2021 · External reference
10.1038/s41579-020-00459-7
10.1038/s41579-020-00459-7 · External reference
Practical Aspects of Otolaryngologic Clinical Services During the 2019 Novel Coronavirus Epidemic: An Experience in Hong Kong [J]
10.1001/jamaoto.2020.0488 · 2020 · External reference
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J]
10.1016/s0140-6736(20)30566-3 · 2020 · External reference
Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) [J]
10.1001/jamacardio.2020.1017 · 2020 · External reference
COVID-19 and the digestive system [J]
10.14309/ajg.0000000000000691 · 2020 · External reference
Gastrointestinal and hepatic manifestations of 2019 novel coronavirus disease in a large cohort of infected patients from New York: clinical implications [J]
10.1053/j.gastro.2020.05.010 · 2020 · External reference
Kidney disease is associated with in-hospital death of patients with COVID-19 [J]
10.1016/j.kint.2020.03.005 · 2020 · External reference
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China [J]
10.1001/jamaneurol.2020.1127 · 2020 · External reference
Ocular manifestations of COVID-19 [J]
10.1016/j.preteyeres.2024.101285 · 2024 · External reference
Cutaneous manifestations of COVID-19: an evidence-based review [J]
10.1007/s40257-020-00558-4 · 2020 · External reference
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study [J]
10.1136/bmj-2021-069761 · 2022 · External reference
10.15585/mmwr.mm7106e2
10.15585/mmwr.mm7106e2 · External reference
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study [J]
10.1016/s0140-6736(22)00327-0 · 2022 · External reference
TUITE A R. Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern [J]
10.1093/cid/ciac174 · 2022 · External reference
10.1038/s41586-021-04266-9
10.1038/s41586-021-04266-9 · External reference
Long-term spatiotemporal analysis of the climate related impact on the transmission rate of COVID-19 [J]
10.1016/j.envres.2023.116741 · 2023 · External reference
10.1016/j.scitotenv.2020.140935
10.1016/j.scitotenv.2020.140935 · External reference
Influence of airborne transmission of SARS-CoV-2 on COVID-19 pandemic. A review [J]
10.1016/j.envres.2020.109861 · 2020 · External reference
A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment [J]
10.1016/j.envres.2020.110612 · 2021 · External reference
Unresolved reference
2021 · External reference
Importance of collecting data on socioeconomic determinants from the early stage of the COVID-19 outbreak onwards [J]
10.1136/jech-2020-214297 · 2020 · External reference
COVID-19 and older adults: what we know [J]
10.1111/jgs.16472 · 2020 · External reference
COVID-19: consider cytokine storm syndromes and immunosuppression [J]
10.1016/s0140-6736(20)30628-0 · 2020 · External reference
10.1016/j.cell.2021.11.033
10.1016/j.cell.2021.11.033 · External reference
Co-infections in people with COVID-19: a systematic review and meta-analysis [J]
10.1016/j.jinf.2020.05.046 · 2020 · External reference
Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19-A Prospective Monocentric Cohort Study [J]
2024 · External reference
Viral and Bacterial Co-Infections in the Lungs: Dangerous Liaisons [J]
10.3390/v13091725 · 2021 · External reference
10.1038/s41590-020-0778-2
10.1038/s41590-020-0778-2 · External reference
Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung [J]
2024 · External reference
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 [J]
10.1038/s41591-020-0901-9 · 2020 · External reference
10.1016/j.chom.2021.05.004
10.1016/j.chom.2021.05.004 · External reference
10.1016/j.jaci.2007.08.046
10.1016/j.jaci.2007.08.046 · External reference
Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner [J]
10.1128/jvi.80.4.1629-1636.2006 · 2006 · External reference
SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? [J]
10.15252/emmm.202012560 · 2020 · External reference
The role of co-infections and secondary infections in patients with COVID-19 [J]
10.1186/s41479-021-00083-w · 2021 · External reference
10.1016/j.chom.2016.01.001
10.1016/j.chom.2016.01.001 · External reference
10.1152/ajplung.00283.2020
10.1152/ajplung.00283.2020 · External reference
10.1128/cmr.00014-10
10.1128/cmr.00014-10 · External reference
SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance [J]
10.1038/s41467-021-24521-x · 2021 · External reference
COVID-19: immunopathogenesis and Immunotherapeutics [J]
10.1038/s41392-020-00243-2 · 2020 · External reference
Immunopathogenesis and treatment of cytokine storm in COVID-19 [J]
10.7150/thno.49713 · 2021 · External reference
10.1038/s41590-021-00937-x
10.1038/s41590-021-00937-x · External reference
10.1038/s41581-020-00357-4
10.1038/s41581-020-00357-4 · External reference
Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza [J]
10.1172/jci.insight.155055 · 2022 · External reference
Cytokine storm intervention in the early stages of COVID-19 pneumonia [J]
10.1016/j.cytogfr.2020.04.002 · 2020 · External reference
10.1038/s12276-021-00602-1
10.1038/s12276-021-00602-1 · External reference
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) [J]
10.7554/elife.86014 · 2023 · External reference
10.1371/journal.ppat.1010176
10.1371/journal.ppat.1010176 · External reference
10.1126/science.abm8108
10.1126/science.abm8108 · External reference
10.1016/j.chom.2014.06.005
10.1016/j.chom.2014.06.005 · External reference
Risks and features of secondary infections in severe and critical ill COVID-19 patients [J]
10.1080/22221751.2020.1812437 · 2020 · External reference
10.1038/s41586-021-03631-y
10.1038/s41586-021-03631-y · External reference
Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients [J]
10.1016/j.xcrm.2021.100229 · 2021 · External reference
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis [J]
10.1016/j.cmi.2020.07.016 · 2020 · External reference
Pulmonary Co-Infections Detected Premortem Underestimate Postmortem Findings in a COVID-19 Autopsy Case Series [J]
2023 · External reference
A Retrospective, Monocentric Study Comparing Co and Secondary Infections in Critically Ill COVID-19 and Influenza Patients [J]
2022 · External reference
Fungal-Bacterial Co-Infections and Super-Infections among Hospitalized COVID-19 Patients: A Systematic Review [J]
2023 · External reference
Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study [J]
10.3389/fmicb.2023.1206476 · 2023 · External reference
10.1515/mr-2021-0034
10.1515/mr-2021-0034 · External reference
10.1111/all.14657
10.1111/all.14657 · External reference
10.1016/s0140-6736(20)30183-5
10.1016/s0140-6736(20)30183-5 · External reference
Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients [J]
10.1111/all.14496 · 2021 · External reference
Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing [J]
10.1038/s41421-020-0168-9 · 2020 · External reference
Serum Ferritin is an independent risk factor for Acute Respiratory Distress Syndrome in COVID-19 [J]
10.1016/j.jinf.2020.09.006 · 2020 · External reference
Relationship between the Viral Load in Patients with Different COVID-19 Severities and SARS-CoV-2 Variants [J]
10.3390/microorganisms12030428 · 2024 · External reference
The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients [J]
10.1016/j.jinf.2021.08.027 · 2021 · External reference
How bad is Omicron? What scientists know so far [J]
10.1038/d41586-021-03614-z · 2021 · External reference
10.1002/mco2.110
10.1002/mco2.110 · External reference
Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort study [J]
10.1016/j.lansea.2023.100348 · 2024 · External reference
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study [J]
10.1016/s0140-6736(22)00462-7 · 2022 · External reference
10.1016/j.virs.2022.07.014
10.1016/j.virs.2022.07.014 · External reference
Comparison of clinical outcomes, demographic, and laboratory characteristics of hospitalized COVID-19 patients during major three waves driven by Alpha, Delta, and Omicron variants in Tehran, Iran [J]
10.1111/irv.13184 · 2023 · External reference
10.1093/cid/ciad045
10.1093/cid/ciad045 · External reference
Risk factors, outcomes, and epidemiological and etiological study of hospitalized COVID-19 patients with bacterial co-infection and secondary infections [J]
10.1007/s10096-024-04755-5 · 2024 · External reference
Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment [J]
10.1016/j.jmii.2022.09.006 · 2022 · External reference
Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling [J]
10.1084/jem.20201241 · 2020 · External reference
10.1016/j.cytogfr.2020.06.001
10.1016/j.cytogfr.2020.06.001 · External reference
EXPRESSION OF CONCERN: Th17 and treg cells function in SARS-CoV2 patients compared with healthy controls [J]
2024 · External reference
Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8 [J
10.1086/338475 · 2002 · External reference
A Review of Antibiotic Efficacy in COVID-19 Control [J]
10.1155/2023/6687437 · 2023 · External reference
Associated Bacterial Coinfections in COVID-19-Positive Patients [J]
2023 · External reference
Severe co-infection caused by difficult-to-diagnose hypermucoviscous Klebsiella pneumoniae K1-ST82 in a patient with COVID-19: a case report [J]
10.1186/s12879-024-10092-x · 2024 · External reference
Ventilator-associated pneumonia in critically ill patients with COVID-19 [J]
10.1186/s13054-021-03460-5 · 2021 · External reference
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study [J]
10.1093/jac/dkaa530 · 2021 · External reference
Early bacterial co-infection in ARDS related to COVID-19 [J]
10.1007/s00134-020-06165-5 · 2020 · External reference
Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection? [J]
10.1093/alcalc/agaa037 · 2020 · External reference
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis [J]
10.1503/cmaj.200645 · 2020 · External reference
10.2478/jtim-2020-0011
10.2478/jtim-2020-0011 · External reference
10.1016/j.it.2024.04.001
10.1016/j.it.2024.04.001 · External reference
10.1001/jama.2023.8823
10.1001/jama.2023.8823 · External reference
Post-acute COVID-19 syndrome [J]
10.1038/s41591-021-01283-z · 2021 · External reference
Characterising long COVID: a living systematic review [J]
10.1136/bmjgh-2021-005427 · 2021 · External reference
Post-acute COVID-19 Syndrome Negatively Impacts Physical Function, Cognitive Function, Health-Related Quality of Life, and Participation [J]
10.1097/phm.0000000000001910 · 2022 · External reference
Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
2025 · External reference
Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 [J]
10.1038/s41590-023-01724-6 · 2024 · External reference
10.1016/j.cell.2020.05.015
10.1016/j.cell.2020.05.015 · External reference
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia [J]
10.7554/elife.63430 · 2020 · External reference
Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for Enterococcus spp [J]
10.3390/biomedicines10112786 · 2022 · External reference
Increased incidence of co-infection in critically ill patients with influenza [J]
10.1007/s00134-016-4578-y · 2017 · External reference
10.1080/21505594.2021.1966996
10.1080/21505594.2021.1966996 · External reference
Viral co-infection with human respiratory syncytial virus in suspected acute and severe respiratory tract infections during COVID-19 pandemic in Yaoundé, Cameroon, 2020-2021 [J]
10.1111/irv.13131 · 2023 · External reference
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy [J]
10.1007/s40262-022-01152-z · 2022 · External reference
10.1016/s2213-2600(22)00528-8
10.1016/s2213-2600(22)00528-8 · External reference
Unresolved reference
2020 · External reference
10.1016/j.biopha.2020.110698
10.1016/j.biopha.2020.110698 · External reference
Dexamethasone in Hospitalized Patients with Covid-19 [J]
10.1056/nejmoa2021436 · 2021 · External reference
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury [J]
10.1016/s0140-6736(20)30317-2 · 2020 · External reference
Clinical findings in 111 cases of influenza A (H7N9) virus infection [J]
10.1056/nejmoa1305584 · 2013 · External reference
Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19
10.1016/j.intimp.2020.107120 · 2021 · External reference
10.1038/s41591-023-02480-8
10.1038/s41591-023-02480-8 · External reference
Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials [J]
10.1186/s12967-024-05358-6 · 2024 · External reference
Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time? [J]
10.1136/thorax-2023-220250 · 2023 · External reference
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety [J]
10.1136/thorax-2022-219795 · 2023 · External reference
10.1016/j.bioorg.2023.106592
10.1016/j.bioorg.2023.106592 · External reference
A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 [J]
10.1097/cm9.0000000000001614 · 2021 · External reference
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial [J]
10.1183/13993003.00380-2022 · 2022 · External reference
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial [J]
10.1183/13993003.04538-2020 · 2022 · External reference
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial [J]
10.1016/s2213-2600(20)30036-9 · 2020 · External reference
A procalcitonin-based algorithm to guide antibiotic use in patients with acute pancreatitis (PROCAP): a single-centre, patient-blinded, randomised controlled trial [J]
10.1016/s2468-1253(22)00212-6 · 2022 · External reference
COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilation [J]
10.1186/s13054-023-04312-0 · 2023 · External reference
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients [J]
10.1007/s00134-023-07161-1 · 2023 · External reference
Contribution of traditional Chinese medicine to the treatment of COVID-19 [J]
10.1016/j.phymed.2020.153279 · 2021 · External reference
10.1016/j.intimp.2019.02.046
10.1016/j.intimp.2019.02.046 · External reference
Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders [J]
10.1016/j.ejmech.2017.03.004 · 2017 · External reference
Plant Spices as a Source of Antimicrobial Synergic Molecules to Treat Bacterial and Viral Co-Infections [J]
2022 · External reference
Remdesivir for the treatment of COVID-19 [J]
2021 · External reference
Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis [J]
10.1370/afm.3120 · 2024 · External reference
10.1038/s41573-023-00672-y
10.1038/s41573-023-00672-y · External reference
10.1126/science.adg7942
10.1126/science.adg7942 · External reference
Nucleic acid drugs: recent progress and future perspectives [J]
10.1038/s41392-024-02035-4 · 2024 · External reference
Old drugs, new tricks: leveraging known compounds to disrupt coronavirus-induced cytokine storm [J]
10.1038/s41540-022-00250-9 · 2022 · External reference
Repurposing of drugs targeting the cytokine storm induced by SARS-CoV-2 [J]
10.1111/bph.15987 · 2023 · External reference
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection [J]
10.1038/s41587-019-0156-5 · 2019 · External reference
Cell therapy: A beacon of hope in the battle against pulmonary fibrosis [J]
10.1096/fj.202402790r · 2025 · External reference
10.1021/acs.analchem.4c01190
10.1021/acs.analchem.4c01190 · External reference
Panton-Valentine Leukocidin-Secreting Staphylococcus aureus Pneumonia Complicating COVID-19 [J]
10.3201/eid2608.201413 · 2020 · External reference
COVID-19 and mycoplasma pneumoniae coinfection [J]
10.1002/ajh.25785 · 2020 · External reference
Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study [J]
10.1016/s1473-3099(20)30176-6 · 2020 · External reference
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features [J]
10.1016/j.jinf.2021.01.009 · 2021 · External reference
Legionnaires' disease in the time of COVID-19 [J]
10.1186/s41479-020-00080-5 · 2021 · External reference
10.2478/jtim-2022-0037
10.2478/jtim-2022-0037 · External reference
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study [J]
10.1016/s0140-6736(20)30211-7 · 2020 · External reference
Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit [J]
10.1007/s15010-021-01643-4 · 2022 · External reference
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020 [J]
10.15585/mmwr.mm6948e1 · 2020 · External reference
Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection [J]
10.1186/s12890-023-02394-8 · 2023 · External reference
Secondary Infections in Critically Ill Patients with COVID-19: A Retrospective Study [J]
2022 · External reference
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study [J]
10.1007/s00134-020-06323-9 · 2021 · External reference
Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation [J]
10.1186/s12879-022-07192-x · 2022 · External reference
Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis [J]
10.1016/s2666-5247(22)00355-x · 2023 · External reference
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London [J]
10.1093/jac/dkaa475 · 2021 · External reference
10.1371/journal.ppat.1012075
10.1371/journal.ppat.1012075 · External reference
Characterization of Prevotella intermedia and Prevotella nigrescens isolates from periodontic and endodontic infections [J]
1994 · External reference
Characterization of oral bacterial and fungal microbiome in recovered COVID-19 patients [J]
10.1186/s12866-023-02872-3 · 2023 · External reference
The characteristics of microbiome in the upper respiratory tract of COVID-19 patients [J]
10.1186/s12866-024-03281-w · 2024 · External reference
Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs [J]
2021 · External reference
Synergistic effects of COVID-19 and Pseudomonas aeruginosa in chronic obstructive pulmonary disease: a polymicrobial perspective [J]
10.1007/s11010-023-04744-w · 2024 · External reference
Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients
10.1186/s13578-022-00748-z · 2022 · External reference
